What are the mechanisms of action for novel extended adjuvant therapies?

G. Thomas Budd, MD

G. Thomas Budd, MD, on advances in extended adjuvant HER2+ early breast cancer.

Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here